Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 15 min ago
Peer-reviewedCC BYJournal of cancer research and clinical oncology

Management of extravasations of enfortumab vedotin and pembrolizumab: a case report and mini review of the current literature

  • Hendrik Dinkel1
  • Konstantin E. Seifert1
  • Martin Bögemann1
  • Andres J. Schrader1
  • Katrin Schlack1
  1. 1Albert-Schweitzer-Campus 1, GB A1, 48149 Münster, Germany
Read full textPDFCite

Related

  1. Concurrent erythema multiforme and psoriasiform eruption during enfortumab vedotin plus pembrolizumab therapy for advanced urothelial carcinoma
    Rossella Di Trolio, Giuseppe Di Lorenzo
    Archive of Clinical CasesPeer-reviewedCC BY-NC 4.0Full textGeneral medicinePMC
  2. Confirmed Myocarditis-Myositis Overlap Without Myasthenia Gravis: Evaluating for Triple M Syndrome Following Combined Enfortumab Vedotin and Pembrolizumab Therapy.
    Bryan Ashong, Yash Ranga
    CureusPeer-reviewedCC BYFull textOncologyEurope PMC
  3. Skin toxicity and effectiveness of first-line enfortumab vedotin plus pembrolizumab for urothelial carcinoma: a prospective multicenter real-world study in Japan.
    K Tamura, T Tsujino, R Taoka +24
    ESMO real world data and digital oncologyPeer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMC
  4. Circulating Tumor DNA Clearance Is Associated with Response and Survival in Metastatic Urothelial Carcinoma Treated with First-Line Enfortumab Vedotin Plus Pembrolizumab
    Adam Khorasanchi, Sayan Mullick Chowdhury, Eric Fei Hong +19
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  5. Skin Toxic Effects and Survival With Enfortumab Vedotin-Pembrolizumab in Advanced Urothelial Carcinoma.
    Zachariah Thomas, Cindy Y Jiang, Patrick J Speck +25
    JAMA network openPeer-reviewedCC BY-NC-NDFull textSurgery & anaesthesiaEurope PMCCrossref

Cite

BibTeXRIS
BibTeX
@article{dinkel2026management,
  title = {{Management of extravasations of enfortumab vedotin and pembrolizumab: a case report and mini review of the current literature}},
  author = {Hendrik Dinkel and Konstantin E. Seifert and Martin Bögemann and Andres J. Schrader and Katrin Schlack},
  journal = {Journal of cancer research and clinical oncology},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13675447},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Management of extravasations of enfortumab vedotin and pembrolizumab: a case report and mini review of the current literature
AU  - Hendrik Dinkel
AU  - Konstantin E. Seifert
AU  - Martin Bögemann
AU  - Andres J. Schrader
AU  - Katrin Schlack
PY  - 2026
DA  - 2026/10/01
JO  - Journal of cancer research and clinical oncology
UR  - https://europepmc.org/article/PMC/PMC13675447
SN  - 0171-5216
SN  - 1432-1335
ER  -